>>Back
NIH taps Genentech drug for pioneering Alzheimer's study
  • Publisher：
  • Publication：2012/5/17
The NIH will help fund a landmark, $100 million study of Genentech's experimental Alzheimer's treatment crenezumab. Researchers will test the drug in Colombians with a particular genetic mutation, aiming to see if the drug can stop Alzheimer's before it starts.


 

Excipients

PHEXCOM is a registered trademark of Shanghai Phexcom Information Technology Co.,Ltd. Copyright 2009-2025 Shanghai Phexcom Information Technology Co.,Ltd. All rights reserved.
版权所有:辅料网 ICP备案编号： 沪ICP备09013362号-1